Literature DB >> 8806680

Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.

R Wienecke1, J C Maize, F Shoarinejad, W C Vass, J Reed, J S Bonifacino, J H Resau, J de Gunzburg, R S Yeung, J E DeClue.   

Abstract

Tuberin is the protein product of the tuberous sclerosis-2 (TSC2) gene, which is associated with tuberous sclerosis (TSC), a human genetic syndrome characterized by the development of tumors in a variety of tissues. We have previously shown that tuberin is a widely expressed 180 kDa protein which exhibits specific GTPase activating activity in vitro towards the Ras-related Rap1 protein. In this study we have used affinity-purified antibodies against tuberin to analyse its expression in human and rat tissues and to examine its subcellular localization. Tuberin expression was detected in all adult human tissues tested, with the highest levels found in brain, heart and kidney, organs that are commonly affected in TSC patients. By contrast, in adult rats the highest levels of tuberin were found in brain, liver and testis. Indirect immunofluorescence of tuberin in various cultured cell lines revealed a punctate, mostly perinuclear staining pattern. Double-indirect immunofluorescence analysis with anti-tuberin sera and antisera against known Golgi markers (mannosidase-II and furin) revealed that the staining of tuberin was consistent with its localization in the stacks of the Golgi apparatus. In support of this, treatment of cells with brefeldin A, a drug known to cause disassembly of the Golgi apparatus, abolished the perinuclear staining of tuberin. Moreover, conventional and confocal immunofluorescence demonstrated co-localization of tuberin with Rap1, which has previously been localized to the Golgi apparatus. The co-localization of tuberin and Rap1 in vivo strengthens the likelihood that the in vitro catalytic activity of tuberin toward Rap1 plays a physiologically relevant role in the tumor suppressor function of tuberin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806680

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.

Authors:  R D York; D C Molliver; S S Grewal; P E Stenberg; E W McCleskey; P J Stork
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.

Authors:  G Rennebeck; E V Kleymenova; R Anderson; R S Yeung; K Artzt; C L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

Authors:  T Soucek; R S Yeung; M Hengstschläger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin.

Authors:  Xiangyu Liu; X F Steven Zheng
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

5.  Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene.

Authors:  T Kobayashi; H Mitani; R Takahashi; M Hirabayashi; M Ueda; H Tamura; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 6.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.

Authors:  J L Arbiser; R Yeung; S W Weiss; Z K Arbiser; M B Amin; C Cohen; D Frank; S Mahajan; G S Herron; J Yang; H Onda; H B Zhang; X Bai; E Uhlmann; A Loehr; H Northrup; P Au; I Davis; D E Fisher; D H Gutmann
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers.

Authors:  G H Xiao; F Jin; A J Klein-Szanto; T L Goodrow; M W Linehan; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

9.  Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.

Authors:  R S Yeung; C D Katsetos; A Klein-Szanto
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

10.  Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.

Authors:  A B Hanker; N Mitin; R S Wilder; E P Henske; F Tamanoi; A D Cox; C J Der
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.